You are here

An Overview of Current Regulatory Requirements for Approval of Biosimilar Insulins

Lutz Heinemann, PhD, Hootan Khatami, MD, Ross McKinnon, PhD and Philip Home, MA, DPhil, DM, FRCP

Diabetes Technology & Therapeutics